This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Newbio Therapeutics, Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Di Zeng: Innovator in Antibody-Drug Conjugates
Introduction
Di Zeng is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. He has been instrumental in developing innovative solutions that enhance the efficacy of drug therapies. With a total of five patents to his name, Zeng's work focuses on advancing medical treatments through novel antibody-drug conjugates.
Latest Patents
Zeng's latest patents include groundbreaking inventions such as anti-CD79b antibodies and drug conjugates. One of his notable patents discloses an anti-CD79b antibody or antigen-binding fragment, which comprises specific amino acid sequences that enhance its binding capabilities. This invention holds promise for targeted therapies in treating diseases. Another significant patent involves tetramaleimide linkers, which are crucial for the preparation of antibody-drug conjugates. These ADCs, derived from Zeng's innovative linkers, exhibit high homogeneity and stability, making them effective for treating various diseases, including tumors.
Career Highlights
Di Zeng is currently associated with Newbio Therapeutics, Inc., where he continues to push the boundaries of biopharmaceutical research. His work has garnered attention for its potential to revolutionize treatment methodologies in oncology and other fields. Zeng's expertise in antibody engineering and drug conjugation has positioned him as a key player in the biotechnology sector.
Collaborations
Zeng collaborates with esteemed colleagues, including Nianhe Han and Deqiang An, who contribute to the innovative projects at Newbio Therapeutics, Inc. Their combined efforts enhance the research and development of cutting-edge therapies.
Conclusion
Di Zeng's contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates, highlight his role as a leading inventor. His innovative patents and collaborations pave the way for advancements in medical treatments, showcasing the impact of his work on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile